LEAP THERAPEUTICS INC (LPTX) Stock Income Statement
NASDAQ:LPTX - Nasdaq - US52187K2006 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 1.50M | 1.50M | |||
| Operating Expenses | 70.06M | 57.46M | 56.76M | 42.93M | 30.04M | |||
| Research and Development | 57.21M | 43.65M | 44.97M | 32.16M | 20.42M | |||
| Selling, General, and Administrative Expenses | 12.85M | 13.81M | 11.80M | 10.77M | 9.62M | |||
| Operating Income | -70.06M | -57.46M | -56.76M | -41.43M | -28.54M | |||
| Interest Income/Expense | 3.09M | 4.03M | 263.00K | -411.00K | 792.00K | |||
| Other Income/Expense | N/A | 1.60M | 2.05M | 1.23M | 231.00K | |||
| Non Recurring Items | N/A | -29.58M | N/A | N/A | N/A | |||
| Income Before Taxes | -66.97M | -81.41M | -54.45M | -40.61M | -27.52M | |||
| Income Tax | 585.00K | 0.00 | 147.00K | -24.00K | -2.00K | |||
| Net Income | -67.79M | -81.41M | -54.60M | -40.59M | -37.59M | |||
| EBITDA | -70.05M | -57.44M | -56.75M | -41.40M | -28.50M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.81 | -3.98 | -4.82 | -4.73 | -6.34 | |||
| Non GAAP EPS | -1.84 | -5.08 | -4.70 | -0.48 | -0.55 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -2705.80% | -2505.87% | |||
| Operating Profit Margin | N/A | N/A | N/A | -2761.73% | -1902.60% | |||
All data in USD